Cure8 research brief
Why This Matters
People with IBD may have a higher-than-expected rate of biopsy-confirmed celiac disease in this Northern Indian cohort, and standard anti-tTG blood tests can be falsely positive in IBD. Confirmatory duodenal biopsy is important before labeling someone with celiac disease.
Who Should Pay Attention
Adult IBD patients (especially those with unexplained symptoms or nutritional issues), gastroenterology clinicians who manage IBD and celiac disease, and researchers studying overlap between immune-mediated gut diseases.
Study Snapshot
What To Know
This was a prospective observational study of 477 IBD patients in Northern India; all had IgA anti-tTG screening and seropositive individuals underwent upper GI endoscopy with duodenal biopsies. Eleven patients had biopsy-proven celiac disease.
The paper emphasizes that anti-tTG screening can yield false positives in IBD, so biopsy confirmation remains important before diagnosing celiac disease.
The study found no clear clinical differences between IBD patients with and without coexisting celiac disease, though a non-significant trend toward more extensive colitis was noted in UC patients with celiac disease. The authors call for larger, multicenter studies to better define the association in Indian populations.
Keep In Mind
The source is an abstract-level report of a single-center prospective observational study. Results are not definitive and the authors recommend larger multicenter studies. The article notes a notable false-positive rate for anti-tTG in IBD, supporting selective screening and histological confirmation.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.